🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer

Charles S. Fuchs, Toshihiko Doi et al. (2018)

JAMA Oncology

1.6K citesjournal articlePDF

Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer

Anne Aupérin, Cecile Le Péchoux et al. (2010)

Journal of Clinical Oncology

1.6K citesjournal articlePDF

Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial

Richard S. Finn, Baek-Yeol Ryoo et al. (2020)

Journal of Clinical Oncology

1.6K citesjournal articlePDF

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

Massimo Cristofanilli, Nicholas C Turner et al. (2016)

The Lancet Oncology

1.6K citesjournal articlePDF

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

Steven J. Cohen, Cornelis J.A. Punt et al. (2008)

Journal of Clinical Oncology

1.6K citesjournal articlePDF

Immunotherapies for hepatocellular carcinoma

Josep M. Llovet, Florian Castet et al. (2021)

Nature Reviews Clinical Oncology

1.7K citesjournal articlePDF

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

Robert C Doebele, Alexander Drilon et al. (2020)

The Lancet Oncology

1.6K citesjournal articlePDF

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer

Matthew P. Goetz, Masakazu Toi et al. (2017)

Journal of Clinical Oncology

1.6K citesjournal articlePDF

Prevalence of pain in patients with cancer: a systematic review of the past 40 years

M.H.J. van den Beuken-van Everdingen, J.M. de Rijke et al. (2007)

Annals of Oncology

1.6K citesjournal articlePDF

HPV-associated head and neck cancer: a virus-related cancer epidemic

Shanthi Marur, Gypsyamber D'Souza et al. (2010)

The Lancet Oncology

1.5K citesjournal articlePDF

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

A H Calvert, D R Newell et al. (1989)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

OncoKB: A Precision Oncology Knowledge Base

Debyani Chakravarty, Jianjiong Gao et al. (2017)

JCO Precision Oncology

1.6K citesjournal articlePDF

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

Wasaburo Koizumi, Hiroyuki Narahara et al. (2008)

The Lancet Oncology

1.5K citesjournal articlePDF

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Eric Pujade-Lauraine, Jonathan A Ledermann et al. (2017)

The Lancet Oncology

1.5K citesjournal articlePDF

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

R. Glynne-Jones, L. Wyrwicz et al. (2017)

Annals of Oncology

1.6K citesjournal articlePDF